Salute e Benessere
Gedeon Richter: Cariprazine shows effectiveness in the treatment of mental health disorders with combined substance use disorder
In addition, Richter and Recordati organized a scientific symposium titled " ", where experts discussed the potential of dopamine receptor partial agonists and the importance of understanding the mechanism of action to differentiate and personalize therapies.
On the 4 of April, during a Scientific Event involving around 100 doctors, the importance of utilizing measurement-based care in everyday psychiatric practice was highlighted: Professor Christoph U. Correll and an expert from Gedeon Richter presented a conditions.
Cariprazine is available in 67 countries globally, and the number of total patients treated from launch in Europe and US is around 1.700.000 (different indications).
Media-contact: Zsuzsa Beke , Head of PR, zs.beke@gedeonrichter.com
View original content:https://www.prnewswire.co.uk/news-releases/gedeon-richter-cariprazine-shows-effectiveness-in-the-treatment-of-mental-health-disorders-with-combined-substance-use-disorder-302423265.html